Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. [Phase 4]
Phase 4 clinical trial update exploring dupilumab for atopic dermatitis monitored with noninvasive imaging.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475) [Phase 3]
Phase 3 trial assessing effectiveness and safety of desloratadine syrup in children with atopic dermatitis and dermatitis conditions; study …
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) [Phase 3]
Phase 3 trial updates evaluate upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis, with results posted in Febr…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial comparing safety and efficacy of Upadacitinib versus Dupilumab in adults with moderate to severe atopic dermatitis has complet…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon) [Phase 2]
Phase II study of HY209 gel for atopic dermatitis completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis [Phase 1, Phase 2]
A clinical trial update investigating safety and efficacy of multiple doses of FURESTEM-AD Inj. for moderate to severe atopic dermatitis in …
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD [Phase 4]
Phase 4 trial update for crisaborole ointment 2% versus vehicle and topical corticosteroids/immune modulators in mild-moderate atopic dermat…
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier [Phase 2]
Phase 2 trial update on a novel moisturiser for atopic dermatitis evaluating skin barrier effects; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis [Phase 3]
Phase 3 trial update for ruxolitinib cream in adolescents and adults with atopic dermatitis; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial evaluating topical ruxolitinib cream for atopic dermatitis in adolescents and adults has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating efficacy and tolerability of Ceradan Advanced Cream in children with atopic dermatitis; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of topical OPA-15406 ointment for atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: A Phase 2 Study of CIM331 for Atopic Dermatitis Patients [Phase 2]
Phase 2 trial of CIM331 for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis [Phase 3]
Phase 3 long-term trial of OPA-15406 ointment in adults and children with atopic dermatitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating risankizumab in adults and adolescents with moderate to severe atopic dermatitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating REGN3500 alone and with dupilumab in adults with moderate-to-severe atopic dermatitis terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). [Phase 3]
Phase 3 ECZTRA 6 evaluated tralokinumab monotherapy in adolescents with moderate to severe atopic dermatitis; the trial completed and result…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 [Phase 3]
ECZTRA 7, a Phase 3 trial evaluating tralokinumab in combination with topical corticosteroids for severe atopic dermatitis, has completed wi…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema [Phase 2]
Phase 2 investigator-initiated trial evaluating apremilast for efficacy in Nummular Eczema (dermatitis) has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update for topical BMX-010 in subjects with psoriasis and atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects [Phase 3]
Phase 3 trial evaluating PF-04965842 for moderate to severe atopic dermatitis (eczema) in patients aged 12 and older; completed with results…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis [Phase 2]
Phase 2 trial update reporting safety and efficacy results for Thykamine in mild-to-moderate atopic dermatitis (eczema).
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating FB-401 in children, adolescents, and adults (2 years and older) with mild to moderate atopic dermatitis ha…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis [Phase 4]
Phase 4 trial investigating different application rates of crisaborole 2% ointment in adults with mild to moderate atopic dermatitis has com…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 trial update on FURESTEM-AD Injection for moderate to severe atopic dermatitis, with safety and efficacy data yet to be determined.